Company Circio Holding ASA

Stocks

TRVX

NO0013033795

Biotechnology & Medical Research

Market Closed - Oslo Bors 11:45:00 2026-10-30 EDT			5-day change	1st Jan Change
10.20 ^NOK	-3.23%		-5.90%	+776.29%

09-23	Circio to Cancel Subsequent NOK200 Million Share Offering	MT
09-20	Circio Holding ASA(OB:CRNA) added to S&P Global BMI Index	CI

Business description: Circio Holding ASA

Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circioâ€™s second clinical program is an immunotherapy targeting KRAS driver mutations.

Number of employees: 11

Sales by Activity: Circio Holding ASA

Fiscal Period: December	2021 (NOK)	2022 (NOK)	2023 (NOK)	2024 (NOK)	2025 (NOK)
Developing Highly Targeted Immunotherapy Treatments	-	10M	123K	-	-

See all business segments

Executive Committee: Circio Holding ASA

Manager	Title	Age	Since
Erik Digman Wiklund CEO	Chief Executive Officer	-	2021-10-19
Lubor Gaal DFI	Director of Finance/CFO	58	2022-03-06
Thomas Hansen CTO	Chief Tech/Sci/R&D Officer	-	2021-12-31
Ola Melin COO	Chief Operating Officer	-	-
Victor Levitsky CTO	Chief Tech/Sci/R&D Officer	-	2020-05-03

See CIRCIO HOLDING ASA governance

Composition of the Board of Directors: Circio Holding ASA

Director	Title	Age	Since
Robert Burns BRD	Director/Board Member	79	2015-06-30
Diane Mellett BRD	Director/Board Member	66	2015-09-13
Damian Marron CHM	Chairman	64	2020-04-28
Thomas Falck BRD	Director/Board Member	60	2022-04-20
Dinah Sah BRD	Director/Board Member	65	2026-08-24

Composition of the Board of Directors

Shareholders: Circio Holding ASA

Name	Stocks	%	Valuation
Høse AS 4.318 %	12,587,341	4.318 %	15 M kr
Vidar Anfinn Taranger 3.805 %	11,090,000	3.805 %	13 M kr
Nordnet Livsforsikring AS 2.684 %	7,824,678	2.684 %	9 M kr
Star Kapital as 2.165 %	6,311,363	2.165 %	7 M kr
KLP Kapitalforvaltning AS 2.163 %	6,303,948	2.163 %	7 M kr

List of CIRCIO HOLDING ASA shareholders

Company details: Circio Holding ASA

Circio Holding ASA

Tordenskiolds gate 2

0160, Oslo

+47 929 51 788

http://www.targovax.com

Bio Therapeutic Drugs

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CIRCIO HOLDING ASA	-3.23%	-5.90%	+930.30%	+65.58%	323M
WUXI APPTEC CO., LTD.	-0.62%	-1.87%	+42.87%	+64.15%	63.77B
ARGENX SE	+0.35%	+3.20%	+14.40%	+81.76%	56.37B
LONZA GROUP AG	+0.53%	+1.96%	+16.24%	+103.35%	54.62B
IQVIA HOLDINGS INC.	-2.81%	-4.31%	+23.50%	+47.83%	44.06B
BEONE MEDICINES AG	-0.33%	-1.93%	+19.28%	+98.80%	42.11B
REVOLUTION MEDICINES, INC.	+0.55%	+2.31%	+225.14%	+866.21%	41B
GENMAB A/S	+3.27%	+47.96%	+112.84%	+96.58%	34.92B
CELLTRION, INC.	+1.22%	-1.44%	+14.57%	+46.95%	32.82B
INSMED INCORPORATED	+0.89%	+20.55%	-40.62%	+349.24%	24.7B
Average	-0.02%	+6.20%	+135.85%	+182.05%	39.47B
Weighted average by Cap.	+0.18%	+5.43%	+48.71%	+176.58%